Traditional Chinese medicine treatment composition aiming at middle and late period primary lung cancer

Abstract

The invention relates to a traditional Chinese medicine treatment composition aiming at middle and late period primary lung cancer. The composition has the following concrete recipe comprising 4 to 6g of radix adenophorae, 4 to 6g of radix glehniae, 2 to 3g of radix ginseng, 5 to 7g of rhodiola rosea, 1 to 3g of stigma of saffron crocus, 2 to 4g of Kansu sandwort herb, 8 to 10g of dwarf lilyturf roots, 8 to 10g of radix asparagi, 8 to 10g of bulbus fritillariae cirrhosae, 8 to 10g of rhizoma sparganii, 8 to 10g of herba hedyotidis diffusae, 8 to 10g of sea-buckthorn, 5 to 7g of herba houttuyniae, 8 to 10g of curcuma zedoary, 11 to 13g of lepidium seeds, 11 to 13g of pollen typhae carbonisatus, 11 to 13g of fruit of trichosanthes, 11 to 13g of cogongrass rhizome, 8 to 10g of radix paeoniae rubra, 8 to 10g of radix paeoniae alba, 11 to 13g of poria cocos, 8 to 10g of coix seeds, 11 to 13g of dried rhizome of rehmannia, 11 to 12g of Chinese angelica, 11 to 13g of rhizoma ligustici wallichii, 8 to 10g of radix scutellariae, 11 to 13g of spica prunellae and 1000 to 2000g of water. Medicinal materials for invigorating qi, promoting blood circulation and clearing away heat and toxic materials in traditional Chinese medicines are combined with medicinal materials for invigorating qi and promoting blood circulation in Tibetan medicines; the effects of tonifying qi and yin, clearing way heat and toxic materials, softening hardness and eliminating phlegm are achieved.

Description

technical field [0001] The invention relates to the field of medicines, in particular to a traditional Chinese medicine treatment composition for middle and advanced primary lung cancer. Background technique [0002] Lung cancer is the most common primary malignant tumor of the lung. The vast majority of lung cancers originate from the bronchial mucosal epithelium, so it is also called bronchial lung cancer. Over the past 50 years, the morbidity and mortality of lung cancer have risen rapidly in countries all over the world, especially in industrialized countries, and lung cancer has ranked first among male patients who died of cancer. More than 40 years ago, among the patients undergoing surgical treatment for lung diseases in China, the vast majority were tuberculosis, followed by bronchiectasis, lung abscess and other pulmonary suppurative infection diseases, and there were only a few cases of lung cancer. It is estimated that by 2025, the number of lung cancer patients ...

AI Technical Summary

Problems solved by technology

However, the side effects and pain brought by radiotherapy and chemotherapy to patients are relatively large. In clinical practice, many patients do not die because their cancer cannot be treated, but because they cannot bear the pain of cancer treatment.